Prevalence of parvovirus B 19 infection in children with aplastic anemia

Vineeta Gupta1, Isha Saini, Gopal Nath

  • 1Departments of Pediatrics and *Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

Indian Pediatrics
|December 21, 2012
PubMed

Insights

Parvovirus B19 infection is common in children with acquired aplastic anemia. This study found a higher prevalence of parvovirus B19 DNA and IgM antibodies in these patients compared to healthy children.

Area of Science:

  • Pediatric Hematology
  • Infectious Diseases
  • Virology

Background:

  • Acquired aplastic anemia in children can have various causes.
  • Parvovirus B19 is a known cause of red blood cell aplasia.

Purpose of the Study:

  • To investigate the prevalence of parvovirus B19 infection in pediatric patients diagnosed with acquired aplastic anemia.
  • To compare the prevalence of parvovirus B19 infection in patients versus healthy controls.

Main Methods:

  • Polymerase Chain Reaction (PCR) was used to detect parvovirus B19 DNA.
  • Enzyme-Linked Immunosorbent Assay (ELISA) was used to detect parvovirus B19 IgM antibodies.
  • 66 pediatric patients with acquired aplastic anemia and 45 healthy children were included.

Main Results:

  • Parvovirus B19 DNA was detected in 27% of patients versus 2% of controls (P = 0.001).
  • Parvovirus B19 IgM antibodies were found in 25.8% of patients compared to 2.2% of controls (P<0.05).
  • No significant differences in clinical or hematological profiles were observed between infected and non-infected patients.

Conclusions:

  • Parvovirus B19 infection is significantly more prevalent in pediatric patients with acquired aplastic anemia.
  • The findings suggest a potential etiological role for parvovirus B19 in acquired aplastic anemia in children.
  • Further research is warranted to explore the specific mechanisms and clinical implications.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...